← Back
$CDT All transactions

CONDUIT PHARMACEUTICALS INC.

A

$ Value

$500K

Shares

154,799

Price

$3

Filed

Jun 13

Insider

Name

Regan Andrew

Title

Chief Executive Officer

CIK

0001991325

Roles

Director Officer 10% Owner

Transaction Details

Transaction Date

2025-06-03

Code

A

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

154,799

Footnotes

Based on the closing price per share of the Issuer's common stock, par value $0.0001 ("Common Stock"), on June 3, 2025. | These shares of Common Stock are owned of record by Manoira Corporation ("Manoira"). On June 3, 2025, the Issuer issued 154,799 shares of Common Stock to Manoira pursuant to that certain joint development agreement (the "Joint Development Agreement") by and between the Issuer and Manoira, representing an up-front consideration of $500,000. | On January 24, 2025, the Issuer effected a 1-for-100 reverse stock split (the "January Reverse Split") and, on May 15, 2025, subsequently effected a 1-for-15 reverse stock split (together with the January 2025 Reverse Split, the "Reverse Splits"). The number of shares of Common Stock reported has been adjusted to give effect to the Reverse Splits. | These shares of Common Stock are owned of record by Corvus Capital Limited ("Corvus"). | These shares of Common Stock are owned of record by Algo Holdings, Inc. ("Algo"). | Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Andrew Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership except to the extent of its or his pecuniary interest therein.

Filing Info

Accession No.

0001641172-25-014963

Form Type

4

Issuer CIK

0001896212

Regan Andrew's History

Date Ticker Type Value
2025-12-08 CDT A $402K
2025-12-08 CDT A $369
2025-09-19 CDT A $769K
2025-06-03 CDT A $500K

Other Insiders at CDT (90d)

Insider Bought Sold Last
Farley Chele Chiavacci 2026-02-19
Taylor Mark Andrew 2026-03-17